Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 2493 results found. Search for [ Indian pharma ]

Results 1740 to 1760 of 2493
Shoaib Zaman
August 8, 2014
\"Global markets closed in the negative on the back of geopolitical tensions... The US approval to targeted air strikes on Iraq was the latest trigger,\" says Sanjeev Zarbade, vice president, Private Client Group Research, Kotak Securities.

Rahul Oberoi
August 1, 2014
The Nifty was at 7,603 at the end of trading on Friday, down 190 points from the start of the week. The steepest fall was seen in the last two trading sessions.

New Delhi, July 30, 2014
The India business of the company recorded 12 per cent growth as against the Indian Pharma Market (IPM) growth of 10 per cent. The company expects to continue the momentum in the months ahead, Ranabaxy said.

New Delhi, July 28, 2014
\"FIIs hold $320 billion of stocks in Indian equity markets,\" the brokerage said in a research note, adding that given the continued FII inflow, more so in a narrowing basket of quality sectors/stocks, a lot of investors worry about limited room to buy.

Tanvi Varma
July 25, 2014
The IT index was the best performer during the week (up 4 per cent) due to a sharp depreciation of the rupee, hope of pick-up in IT spending in the US and Europe and better prospects than the cyclical sectors.

Shoaib Zaman and Rahul Oberoi
August 18, 2014
Money Today brings you investing lessons from the world's greatest value investors such as Warren Buffett, Benjamin Graham and David Dreman and 10 stocks that pass the tough quality tests prescribed by investing legend John Neff.

Mumbai, July 24, 2014
Brokers said profit-booking at record level by participants, who had been accumulating stocks of bluechip companies on the back of encouraging first quarter earnings and positive economic data, snapped seven-session winning streak.

Neetu Chandra Sharma
New Delhi, July 24, 2014
The pricing anomaly has been caught by National Pharmaceutical Pricing Authority which has filed 22 cases this year alone, sending out demand notices that add up to Rs 221.78 crore.

Sophie Sassard and Zeba Siddiqui
July 22, 2014
GSK is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of off-patent drugs marketed in North America and western Europe with annual sales of around 1 billion pounds ($1.7 billion).

E Kumar Sharma
July 15, 2014
\"By issuing a price control order under Para 19 without any consultation with the industry bodies, the NPPA has shocked and disappointed the pharma industry,\" said Shailesh Ayyangar, Managing Director India and Vice-President (South Asia), Sanofi India Limited, one of the companies likely to be affected by this move.  

Shamni Pande
July 16, 2014
The Annual BT-PeopleStrong Survey puts back the spotlight on the power of employer's brand value. The new-age companies and legacy organisations have melded into our culture.

E Kumar Sharma
July 10, 2014
On service taxes, withdrawal of exemption in case of technical testing of newly developed drugs on humans, is being seen as a negative by the pharma industry.

Aditi Khanna
London, July 8, 2014
In the wake of company's announcement in India of plans to invest 100 million pounds in its British subsidiary alongside the UK government, Chairman YK Hamied appealed to the Indian government to also do more in the field.

New Delhi, July 5, 2014
Over a period of time, Indian players have steadily migrated up the value chain to focus on value-added formulations with higher margins. As a result, India is today severely dependent on imports for many essential and large-volume drugs, it said.

E. Kumar Sharma
July 5, 2014
In its latest July 2014 report on the Indian Pharmaceutical industry, the Associated Chambers of Commerce & Industry of India (Assocham) urges the government to \"promote the setting up of vertically integrated manufacturing facilities for essential drugs, at a competitive scale.\"

Mumbai, July 4, 2014
The mergers and acquisition (M&A) activity involving domestic companies jumped 21.9 per cent at $20.5 billion in the first half of 2014 over the same period last year, says a report.

E. Kumar Sharma
July 2, 2014
Given the optimistic mood in the country about the reform process, Satish Reddy, President of the Indian Pharmaceutical Alliance (IPA) and Chairman at Dr Reddy's Labs, said that \"the industry will be looking for signals of revival of the growth story\".

Mumbai, July 1, 2014
Buying by foreign funds amid positive global cues also boosted the domestic sentiment. The decision to increase diesel, petrol and non-subsidised LPG prices after hiking railway freight and fare was interpreted by investors as the government's resolve to take tough decisions, said brokers.

Anand Adhikari
July 15, 2014
The CDR mechanism was created in early 2000 to help distressed corporates with a loan exposure of over Rs 10 crore. If a CDR fails, the asset is classified as an NPA. Today, many corporates are going down despite huge debt restructuring packages.

Lalit K Jha
Boston, June 28, 2014
Top executives of American pharma companies favour \"dialogue\" with India and \"not confrontation\" to address their concerns on key issues like the protection of intellectual property (IP) and clinical trials.

PAGES 88 OF 125  8687888990